Higher Blood 25(OH)D Level May Reduce the Breast Cancer Risk: Evidence from a Chinese Population Based Case-Control Study and Meta-Analysis of the Observational Studies

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chen, Peizhan ^a   Li, Mian ^a   Gu, Xiaoli ^b   Liu, Yanling ^a   Li, Xiaoguang ^a   Li, Chenglin ^a   Wang, Yuan ^a   Xie, Dong ^a   Wang, Fudi ^a   Yu, Chen ^c   Li, Jingquan ^a   Chen, Xinlei ^a   Chu, Ruiai ^a   Zhu, Jianmin ^c   Ou, Zhouluo ^b   Wang, Hui ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c Xuhui Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; RISK REDUCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D;

EID: 84873867371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049312     Document Type: Article

References (54)

1. Holick MF, Frommer JE, McNeill SC, Richtand NM, Henley JW, et al. (1977) Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 76: 107-114.
2. Okano T, Yasumura M, Mizuno K, Kobayashi T, (1978) In vivo and in vitro conversion of 7-dehydrocholesterol into vitamin D3 in rat skin by ultraviolet ray's irradiation. J Nutr Sci Vitaminol (Tokyo) 24: 47-56.
3. Hollis BW, (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 135: 317-322.
4. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, et al. (1997) 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277: 1827-1830.
5. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349.
6. Holick MF, (1996) Vitamin D and bone health. J Nutr 126: 1159S-1164S.
7. Dawson-Hughes B, (1998) Vitamin D and calcium: recommended intake for bone health. Osteoporos Int 8Suppl 2: S30-34.
8. Martini LA, Wood RJ, (2006) Vitamin D status and the metabolic syndrome. Nutr Rev 64: 479-486.
9. Boucher BJ, (2011) Vitamin D insufficiency and diabetes risks. Curr Drug Targets 12: 61-87.
10. Brewer LC, Michos ED, Reis JP, (2011) Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 12: 54-60.
11. Howland RH, (2011) Vitamin D and depression. J Psychosoc Nurs Ment Health Serv 49: 15-18.
12. Hewison M (2011) An update on vitamin D and human immunity. Clin Endocrinol (Oxf).
13. Deeb KK, Trump DL, Johnson CS, (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7: 684-700.
14. Ma Y, Zhang P, Wang F, Yang J, Liu Z, et al. (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775-3782.
15. Donkena KV, Young CY, (2011) Vitamin d, sunlight and prostate cancer risk. Adv Prev Med 2011: 281863.
16. Ramnath N, Kim S, Christensen PJ, (2011) Vitamin D and lung cancer. Expert Rev Respir Med 5: 305-309.
17. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, et al. (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25: 479-485.
18. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N, (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27: 3757-3763.
19. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, et al. (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991.
20. Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, et al. (2010) Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 28: 4191-4198.
21. Zinser GM, Suckow M, Welsh J, (2005) Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol 97: 153-164.
22. Zinser GM, Welsh J, (2004) Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25: 2361-2372.
23. Chen P, Hu P, Xie D, Qin Y, Wang F, et al. (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121: 469-477.
24. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, et al. (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 76: 874-878.
25. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
26. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
27. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, et al. (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14: 1991-1997.
28. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100: 1581-1591.
29. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, et al. (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17: 889-894.
30. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, et al. (2009) Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res 11: R64.
31. Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, et al. (2009) Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 18: 2655-2660.
32. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J, (2010) Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer 127: 2159-2168.
33. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, et al. (2010) Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 19: 2341-2350.
34. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, et al. (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res 13: R50.
35. Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, et al. (2012) 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133: 1077-1088.
36. Neuhouser ML, Manson JE, Millen A, Pettinger M, Margolis K, et al. (2012) The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women. Am J Epidemiol 175: 673-684.
37. Veldhuis S, Wolbers F, Brouckaert O, Vermes I, Franke HR, (2011) Cancer prevalence in osteoporotic women with low serum vitamin D levels. Menopause 18: 319-322.
38. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 29: 93-99.
39. Abbas S, Chang-Claude J, Linseisen J, (2009) Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 124: 250-255.
40. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, et al. (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2: 598-604.
41. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, et al. (2011) Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One 6: e17251.
42. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, et al. (2012) Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23: 1149-1162.
43. Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA, (2012) The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels. Ann Surg Oncol 19: 2590-2599.
44. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, et al. (2005) Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41: 1164-1169.
45. Pazdiora P, Svobodova S, Fuchsova R, Kucera R, Prazakova M, et al. (2011) Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study. Anticancer Res 31: 3619-3621.
46. Imtiaz S, Siddiqui N, Raza SA, Loya A, Muhammad A, (2012) Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocrinol Metab 16: 409-413.
47. Woo J, Lam CW, Leung J, Lau WY, Lau E, et al. (2008) Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong. Br J Nutr 99: 1330-1334.
48. Lu L, Yu Z, Pan A, Hu FB, Franco OH, et al. (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32: 1278-1283.
49. Palmieri C, MacGregor T, Girgis S, Vigushin D, (2006) Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 59: 1334-1336.
50. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, et al. (2011) Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 18: 1830-1836.
51. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, et al. (2011) Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 13: R74.
52. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, et al. (2009) High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27: 2151-2156.
53. Vashi PG, Trukova K, Lammersfeld CA, Braun DP, Gupta D, (2010) Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J 9: 60.
54. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP, (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591.